Home
Pharma
HealthTech
Physicians
Technology
Clinical
Patientcare
PMDA
Search
Monday, May 21, 2018
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
news
Home
Pharma
HealthTech
Physicians
Technology
Clinical
Patientcare
PMDA
Home
PMDA
PMDA
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
PMDA
Revisions of PRECAUTIONS:Aripiprazole, etc. posted
akthealth
-
January 11, 2018
PMDA
“PMDA Medical Safety Information No.52” Posted
PMDA
Revisions of PRECAUTIONS: Medical Devices Containing Chlorhexidine Gluconate or Chlorhexidine Hydrochloride posted
PMDA
[PMDA]Annual Report FY 2016 posted
PMDA
PRECAUTIONS in the Package Insert of Medical Devices Containing Chlorhexidine Gluconate or Chlorhexidine Hydrochloride posted
PMDA
“PMDA Medical Safety Information No.50” Posted
akthealth
-
March 27, 2017
0
PMDA
PMDA Alert for Proper Use of Drugs: No.11
akthealth
-
March 21, 2017
0
PMDA
Revisions of PRECAUTIONS: Lamotrigine, etc. posted
akthealth
-
March 21, 2017
0
PMDA
Revised “PMDA Medical Safety Information No.33” Posted
akthealth
-
March 6, 2017
0
PMDA
Points to Consider regarding the Notification and Publication of Package Insert...
akthealth
-
February 21, 2017
1
PMDA
Revisions of PRECAUTIONS: Hydroxyzine Hydrochloride, etc. posted
akthealth
-
February 21, 2017
5
PMDA
[PMDA]“Rational Medicine” Initiative posted
akthealth
-
February 21, 2017
1
1
2
Page 2 of 2
MOST POPULAR
NICE nod for psoriatic arthritis drugs Cimzia and Cosentyx
May 24, 2017
Verona Pharma begins dosing RPL554 in Phase IIb COPD trial
July 26, 2017
Biogen takes up option to co-develop Eisai AD drug
October 24, 2017
Tecentriq/Avastin combo hits progression-free survival target
December 13, 2017
Load more
HOT NEWS
Pharma
Verona Pharma begins dosing RPL554 in Phase IIb COPD trial
Clinical
EMA Issues Guideline on Trial Protocol Breaches
Clinical
FDA Finalizes Guidance for Developing Hepatitis C Antivirals
Pharma
EU green light for Novartis’ Rydapt
